Ronan Levy

Ronan Levy, co-founder and executive chairman of Field Trip Health, dives into the evolving psychedelics industry. He discusses the resurgence of therapies like ketamine and psilocybin for mental health, highlighting their potential benefits when used in structured therapeutic settings. Listeners raise concerns about commercialization and ethics in psychedelics, prompting a thoughtful exploration of capitalism's impact. Finally, Ronan shares techniques for maintaining the transformative feelings of wonder that accompany psychedelic experiences.

In this engaging conversation, Ronan Levy, co-founder and Executive Chairman of Field Trip Health, shares his journey from securities lawyer to a leader in psychedelic therapies. He discusses the groundbreaking FT-104 molecule, designed to revolutionize mental health treatment with a faster onset and shorter duration than psilocybin. Ronan also elaborates on innovative tools like the Trip app for enhancing therapeutic experiences, the potential for psychedelic practices in urban settings, and the societal impact of embracing these new methods for healing.

In this insightful discussion, Ronan Levy, Co-founder of Field Trip Psychedelics, and scientist Marshall Tyler explore the innovative landscape of psychedelic-enhanced psychotherapy. They delve into the transformative potential of psychedelics for mental wellness, including ketamine and psilocybin therapies. The conversation unveils how these treatments can foster creativity and emotional insights. They also highlight the integration of biohacking tools and microdosing practices to enhance therapeutic outcomes in a supportive, spa-like environment.